Global Anti-Migraine Drugs Market Size, Status, Research and Forecast 2019

Published On: Sep 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 60446

In 2018, the global Anti-Migraine Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Anti-Migraine Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-Migraine Drugs development in United States, Europe and China.

The key players covered in this study
Eli Lilly
Abbott Laboratories
Eisai
Allergan
Endo
GlaxoSmithKline
Impax Laboratories
Pfizer
AstraZeneca
Bayer
Johnson & Johnson
Merck
Teva
Amgen

Market segment by Type, the product can be split into
Triptans
Ergots
Others

Market segment by Application, split into
Women
Men

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Anti-Migraine Drugs status, future forecast, growth opportunity, key market and key players.
To present the Anti-Migraine Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anti-Migraine Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Anti-Migraine Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Triptans
1.4.3 Ergots
1.4.4 Others
1.5 Market by Application
1.5.1 Global Anti-Migraine Drugs Market Share by Application (2014-2025)
1.5.2 Women
1.5.3 Men
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Anti-Migraine Drugs Market Size
2.2 Anti-Migraine Drugs Growth Trends by Regions
2.2.1 Anti-Migraine Drugs Market Size by Regions (2014-2025)
2.2.2 Anti-Migraine Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Anti-Migraine Drugs Market Size by Manufacturers
3.1.1 Global Anti-Migraine Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Anti-Migraine Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Anti-Migraine Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Anti-Migraine Drugs Key Players Head office and Area Served
3.3 Key Players Anti-Migraine Drugs Product/Solution/Service
3.4 Date of Enter into Anti-Migraine Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Anti-Migraine Drugs Market Size by Type (2014-2019)
4.2 Global Anti-Migraine Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Anti-Migraine Drugs Market Size (2014-2019)
5.2 Anti-Migraine Drugs Key Players in United States
5.3 United States Anti-Migraine Drugs Market Size by Type
5.4 United States Anti-Migraine Drugs Market Size by Application

6 Europe
6.1 Europe Anti-Migraine Drugs Market Size (2014-2019)
6.2 Anti-Migraine Drugs Key Players in Europe
6.3 Europe Anti-Migraine Drugs Market Size by Type
6.4 Europe Anti-Migraine Drugs Market Size by Application

7 China
7.1 China Anti-Migraine Drugs Market Size (2014-2019)
7.2 Anti-Migraine Drugs Key Players in China
7.3 China Anti-Migraine Drugs Market Size by Type
7.4 China Anti-Migraine Drugs Market Size by Application

8 Japan
8.1 Japan Anti-Migraine Drugs Market Size (2014-2019)
8.2 Anti-Migraine Drugs Key Players in Japan
8.3 Japan Anti-Migraine Drugs Market Size by Type
8.4 Japan Anti-Migraine Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Anti-Migraine Drugs Market Size (2014-2019)
9.2 Anti-Migraine Drugs Key Players in Southeast Asia
9.3 Southeast Asia Anti-Migraine Drugs Market Size by Type
9.4 Southeast Asia Anti-Migraine Drugs Market Size by Application

10 India
10.1 India Anti-Migraine Drugs Market Size (2014-2019)
10.2 Anti-Migraine Drugs Key Players in India
10.3 India Anti-Migraine Drugs Market Size by Type
10.4 India Anti-Migraine Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Anti-Migraine Drugs Market Size (2014-2019)
11.2 Anti-Migraine Drugs Key Players in Central & South America
11.3 Central & South America Anti-Migraine Drugs Market Size by Type
11.4 Central & South America Anti-Migraine Drugs Market Size by Application

12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Anti-Migraine Drugs Introduction
12.1.4 Eli Lilly Revenue in Anti-Migraine Drugs Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 Abbott Laboratories
12.2.1 Abbott Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Anti-Migraine Drugs Introduction
12.2.4 Abbott Laboratories Revenue in Anti-Migraine Drugs Business (2014-2019)
12.2.5 Abbott Laboratories Recent Development
12.3 Eisai
12.3.1 Eisai Company Details
12.3.2 Company Description and Business Overview
12.3.3 Anti-Migraine Drugs Introduction
12.3.4 Eisai Revenue in Anti-Migraine Drugs Business (2014-2019)
12.3.5 Eisai Recent Development
12.4 Allergan
12.4.1 Allergan Company Details
12.4.2 Company Description and Business Overview
12.4.3 Anti-Migraine Drugs Introduction
12.4.4 Allergan Revenue in Anti-Migraine Drugs Business (2014-2019)
12.4.5 Allergan Recent Development
12.5 Endo
12.5.1 Endo Company Details
12.5.2 Company Description and Business Overview
12.5.3 Anti-Migraine Drugs Introduction
12.5.4 Endo Revenue in Anti-Migraine Drugs Business (2014-2019)
12.5.5 Endo Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Details
12.6.2 Company Description and Business Overview
12.6.3 Anti-Migraine Drugs Introduction
12.6.4 GlaxoSmithKline Revenue in Anti-Migraine Drugs Business (2014-2019)
12.6.5 GlaxoSmithKline Recent Development
12.7 Impax Laboratories
12.7.1 Impax Laboratories Company Details
12.7.2 Company Description and Business Overview
12.7.3 Anti-Migraine Drugs Introduction
12.7.4 Impax Laboratories Revenue in Anti-Migraine Drugs Business (2014-2019)
12.7.5 Impax Laboratories Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Anti-Migraine Drugs Introduction
12.8.4 Pfizer Revenue in Anti-Migraine Drugs Business (2014-2019)
12.8.5 Pfizer Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Anti-Migraine Drugs Introduction
12.9.4 AstraZeneca Revenue in Anti-Migraine Drugs Business (2014-2019)
12.9.5 AstraZeneca Recent Development
12.10 Bayer
12.10.1 Bayer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Anti-Migraine Drugs Introduction
12.10.4 Bayer Revenue in Anti-Migraine Drugs Business (2014-2019)
12.10.5 Bayer Recent Development
12.11 Johnson & Johnson
12.12 Merck
12.13 Teva
12.14 Amgen

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details